PBIGF   $0.66  -19.14% Market Closed

PARADIGM BIOPHARMACEUTICL
Total Cash 17.87M
totalCashPerShare 0.051
EBITDA -64.97M
Total Debt 239.33K
quickRatio 6.831
currentRatio 7.219
Total Revenue
debtToEquity 1.005
Revenue/Share
ROA -0.86164004
ROE -1.51395
grossProfits
freeCashflow -48.04M
operatingCashflow -65.94M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 31.60M
forwardPE
floatShares 310.26M
sharesOutstanding 350.07M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.14%
heldPercentInstitutions 0.17%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.068
Price To Book help_outline 2.07
earningsQuarterlyGrowth
netIncomeToCommon -58.65M
trailingEps -0.13%
forwardEps
enterpriseToEbitda -0.49
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 12
lastUpdated Nov. 7, 2024, 2:57 a.m.